Literature DB >> 2174061

Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.

E M Valverius1, F Ciardiello, N E Heldin, B Blondel, G Merlo, G Smith, M R Stampfer, M E Lippman, R B Dickson, D S Salomon.   

Abstract

The proto-oncogene c-myc and the oncogene SV40T, both of which have been implicated in the process of cellular immortalization in vitro, have been introduced via amphotropic retroviral expression vectors into the human mammary epithelial cell (HMEC) line 184A1N4 (A1N4). Two stable cell lines were established by growth in selective medium and were found to overexpress either c-myc (A1N4-myc) or SV40T antigen (A1N4-T). Neither the A1N4, A1N4-myc, or A1N4-T cells will grow in soft agar or form tumors in nude mice. However, A1N4-T or A1N4-myc cells, but not the parental A1N4 cells, form colonies in soft agar in response to either epidermal growth factor (EGF), transforming growth factor alpha (TGF alpha), or basic fibroblast growth factor (bFGF). Like EGF and TGF alpha, bFGF is moderately mitogenic for the anchorage-dependent growth (ADG) of all three cell lines. Further, co-cultivation of A1N4-T or A1N4-myc cells with primary diploid mammary fibroblasts can also induce the anchorage-independent growth (AIG) and stimulate the ADG of A1N4-T or A1N4-myc. In addition, conditioned medium obtained from these mammary fibroblasts also stimulated the AIG of the A1N4-T and A1N4-myc cells and was found to contain immunoreactive TGF alpha and bioactive FGF. The mammary fibroblasts express specific mRNA transcripts for bFGF and acidic FGF (aFGF). These results suggest that growth factors such as TFG alpha or FGF, which may be derived from the adjacent mammary stroma, might influence in a paracrine manner the phenotypic characteristics of a population of human mammary epithelial cells toward transformation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2174061     DOI: 10.1002/jcp.1041450204

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  Antitumor effect of MAb EMD 55900 depends on EGF-R expression and histopathology.

Authors:  Christine Solbach; Anja Sterner-Kock; Marc Roller; Hans Georg Schnürch; Manfred Stegmüller; Gudrun Caspar-Bell; Petra Maria Schumm-Draeger; Manfred Kaufmann; Rainald Knecht
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  Overexpression of c-Myc alters G(1)/S arrest following ionizing radiation.

Authors:  Joon-Ho Sheen; Robert B Dickson
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

3.  Oncogene-induced basement membrane invasiveness in human mammary epithelial cells.

Authors:  E W Thompson; J Torri; M Sabol; C L Sommers; S Byers; E M Valverius; G R Martin; M E Lippman; M R Stampfer; R B Dickson
Journal:  Clin Exp Metastasis       Date:  1994-05       Impact factor: 5.150

Review 4.  Anti-invasion drugs.

Authors:  R B Dickson; M D Johnson; M Maemura; J Low
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 5.  Stroma in breast development and disease.

Authors:  Lisa M Arendt; Jenny A Rudnick; Patricia J Keller; Charlotte Kuperwasser
Journal:  Semin Cell Dev Biol       Date:  2009-10-24       Impact factor: 7.727

Review 6.  EGF receptor expression, regulation, and function in breast cancer.

Authors:  S A Chrysogelos; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994-01       Impact factor: 4.872

7.  A flow cytometric study of c-erbB-3 expression in breast cancer.

Authors:  I Brotherick; B K Shenton; B Angus; I S Waite; C H Horne; T W Lennard
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

8.  Mechanisms of EGF receptor regulation in breast cancer cells.

Authors:  S A Chrysogelos; R I Yarden; A H Lauber; J M Murphy
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

9.  Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance.

Authors:  C Yiangou; J J Gomm; R C Coope; M Law; Y A Luqmani; S Shousha; R C Coombes; C L Johnston
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues.

Authors:  Y A Luqmani; M Graham; R C Coombes
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.